PCM
NEO icon

Penserra Capital Management’s NeoGenomics NEO Stock Holding History

Penserra Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,892
Closed -$189K – 901
2019
Q4 		$189K Buy
+5,892
New +$140K 0.01% 462
2019
Q2 		– Sell
-14,432
Closed -$295K – 838
2019
Q1 		$295K Buy
+14,432
New +$251K 0.02% 307

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Penserra Capital Management's NEO Position: Q1 2020 in Review

Penserra Capital Management sold out of NeoGenomics (NEO) in Q1 2020, closing a stake of 5,892 shares — an estimated $189K sold.

Penserra Capital Management first reported a position in NEO in Q1 2019 and held it in 2 quarters. The position peaked at $295K in Q1 2019. 272 funds tracked by Wall St. Rank hold NEO as of Q1 2020.

  • Penserra Capital Management reported no remaining NeoGenomics position as of Q1 2020 after selling out during the quarter.
  • Penserra Capital Management sold 5,892 NeoGenomics shares in Q1 2020, an estimated $189K.
  • Penserra Capital Management first reported a position in NeoGenomics in Q1 2019 and held it in 2 quarters.
  • Penserra Capital Management's NeoGenomics position peaked at $295K in Q1 2019.
  • 272 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2020.

Based on Penserra Capital Management's 13F filing for Q1 2020, filed 14 May 2020.